Skip to search formSkip to main contentSkip to account menu

osteoclast proliferation

The multiplication or reproduction of osteoclasts, resulting in the expansion of an osteoclast cell population. An osteoclast is a specialized… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The Regulation of p27 Kip-1 and Bcl2 Expression Is Involved in the Decrease of Osteoclast Proliferation by A2B Adenosine Receptor Stimulation
A2B adenosine receptor (A2BAR) is known to be a regulator of bone homeostasis, but the regulatory mechanism of A2BAR on the… 
2016
2016
Different functions of the two isoforms of osteopontin (iOPN and sOPN) in the proliferation and differentiation of osteoblast and osteoclast: iOPN inhibits osteoclasts’ proliferation while sOPN…
Osteopontin (OPN) plays an important role in maintaining bone homeostasis. However, functions of its two isoforms (iOPN and sOPN… 
2013
2013
The Preventive Effect of Biochanin A on Bone Loss in Ovariectomized Rats: Involvement in Regulation of Growth and Activity of Osteoblasts and Osteoclasts
Biochanin A (BCA) is a major isoflavone abundant in red clover (Trifolium pretense). The protective effect of BCA on bone loss in… 
2013
2013
Erratum to “The Preventive Effect of Biochanin A on Bone Loss in Ovariectomized Rats: Involvement in Regulation of Growth and Activity of Osteoblasts and Osteoclasts”
Biochanin A (BCA) is a major isoflavone abundant in red clover (Trifolium pretense). The protective effect of BCA on bone loss in… 
2009
2009
Zoledronic Acid on Serum Dickkopf-1 , Osteoprotegerin , and RANKL in Patients with Paget ’ s Disease
implicated in the pathogenesis of many bone diseases, including PDB [2, 6] . Agents used in the treatment of PDB are expected to… 
Review
2006
Review
2006
Individualization of bisphosphonate therapy
According to the literature, 30-90% of patients with advanced cancer will develop skeletal metastases. Carcinomas of the breast… 
2006
2006
Breast Cancer: BisphosphonateTherapy for Metastatic Bone Disease
The indications of bisphosphonate therapy in breast cancer patients go from the correction of hypercalcemia to the prevention of… 
2004
2004
Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506.
1988
1988
Tumor‐bone interaction induced by transplantable human tumors in nude mice
Tumor‐bone interactions were experimentally studied using four transplantable human urogenital tumors in nude mice. The method… 
1981
1981
Malignant osteopetrosis: a disease of abnormal osteoclast proliferation.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)